)
Visual
earnings real time
Proteomics International Laboratories
Proteomics International Laboratories (PIQ) investor relations material
Proteomics International Laboratories Investor Presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor Presentation summary11 Dec, 2025
Commercial launch and product pipeline
Four first-in-class diagnostic tests launching in FY26 across Australia and the USA, targeting diabetic kidney disease, endometriosis, esophageal cancer, and oxidative stress-related muscle damage.
Tests validated in large clinical studies, offering significant advantages over current standards of care and addressing large unmet medical needs.
Consumer-driven strategy focuses on primary care and GP clinics, supported by a digital platform and engagement with key opinion leaders.
Commercial ramp-up underway for PromarkerD and PromarkerEso, with initial sales achieved and further launches planned.
Patented products and attractive margins position the company for licensing agreements and strategic partnerships.
Market strategy and partnerships
Emphasis on building market awareness and adoption through digital and traditional channels, targeting both end users and potential licensing partners.
Reimbursement pricing for PromarkerD in the USA is imminent, with other tests to follow, supporting near-term revenue growth.
Flexible partnering options include non-exclusive and exclusive licensing, with ongoing discussions with global health and diagnostic companies.
Platform and infrastructure enable rapid tech transfer and product launch, enhancing attractiveness for partners.
Industry and government focus on precision medicine creates additional demand for novel diagnostics.
Financial and operational highlights
Market capitalisation of A$67m as of December 2025, with A$12.7m in cash and a recent A$12m capital raise completed.
Quarterly cash receipts of A$1.8m and cash burn of A$1m in Q1 FY26, supported by a revenue-generating bioanalytical services business.
State-of-the-art laboratories and a US CLIA-certified reference lab established, with headquarters in Perth, WA.
Top 40 shareholders hold 41% of shares, with directors holding 11%, indicating strong alignment.
Fully funded to execute launch strategies and drive commercialisation in FY26.
What is the PromarkerD US Medicare pricing strategy?
Licensing strategy for Promarker tests
Detail the consumer-driven sales strategy for GPs
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- NAZARA
Q1 FY25 saw strong revenue, PAT growth, and major acquisitions fueling future expansion. - SNP
Q4 2025 clean CCS operating result rose 41%, but E&P impairments led to a net loss. - GEHC
Strong 2025 results, record backlog, and margin expansion set up robust 2026 growth. - 4503
Revenue and profit surged on strategic brands, cost savings, and raised full-year forecasts. - BDN
2026 targets FFO growth, higher occupancy, asset sales, and further deleveraging. - ENT
2025 saw $2.8B revenue, $220M EBITDA, $270M cash to parents; 2026 outlook: $3.1–$3.2B revenue. - KREF
Net loss for 2025, but strong liquidity, portfolio repositioning, and active capital management. - ORN
Acquisition expands marine construction scale, capabilities, and long-term growth prospects. - RSVR
Q3 revenue up 8% year-over-year; guidance raised on strong publishing and M&A activity. - IEX
Record HST orders and margin gains support 2026 growth outlook amid macro uncertainties.
Next Proteomics International Laboratories earnings date
H1 202623 Feb, 2026
Proteomics International Laboratories
Next Proteomics International Laboratories earnings date
H1 202623 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Proteomics International Laboratories Ltd is an Australian life sciences company specializing in predictive diagnostics and analytical services based on proteomics, the study of proteins. The company develops diagnostic tests for chronic diseases, with a focus on its flagship product, PromarkerD, a predictive test for diabetic kidney disease. In addition to diagnostics, Proteomics International provides contract research services, including protein analysis, biomarker discovery, and pharmaceutical testing, supporting drug development and medical research. Proteomics International Laboratories Ltd is headquartered in Perth, Australia, and its shares are listed on the ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage